NCT01125800 2017-03-20A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MBNovartisPhase 1/2 Completed76 enrolled 18 charts